Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures [Phase 4]

View source ↗

Summary

Phase 4 trial comparing levetiracetam to valproate in idiopathic generalized tonic-clonic seizures has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)
  • Valproate (valproate)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Epilepsy, Idiopathic Generalized | Phase 4 | Status: COMPLETED | Results posted: 2022-02-17